Product Range - Fresenius Medical Care Sverige AB

Acute Therapy Systems 

Product Range

Continuous renal replacement therapy 

Multifunctional and easy to use 

Fresenius Medical Care has always focused on 

services for people. 

We concentrate on the patients’ health as well as 

the staff in the clinics. 

In this brochure you will find a comprehensive 

product range for acute renal replacement and 

plasma therapy. These disposables and solutions 

from Fresenius Medical Care have been specially 

developed for the use in life-threatening situations. 

Acute renal replacement therapy with 

Fresenius Medical Care: 

• Reliable 

• Convenient 

• Effective 

In combination with the multiFiltrate the disposables 

and solutions provide effective and safe treatments for 

patients. The products are specially designed to com- 

plement each other. As a result this enables nursing staff 

to focus on patient care. In this brochure you will find 

a number of benefits for patients, doctors and nurses.

Contents 

multiFiltrate acute therapy system ......................................................... 4 

Complete kits for multiFiltrate ................................................................ 6 

multiFiltrate: paediatric CRRT and SCUF ........................................... 10 

CRRT haemofilters ............................................................................ 12 

Plasmafilters ...................................................................................... 13 

Solutions ........................................................................................... 14 

Temporary dialysis catheters .............................................................. 20 

Disposables and accessories ............................................................. 21 

Technical changes reserved Product Range – 01. 2010 

3

multiFiltrate 

Acute therapy system 

Multifunctional and easy to use 

Safe and easy handling is one of the main requirements 

for a modern, multifunctional acute therapy system. 

The multiFiltrate features an ergonomical and intuitive 

operating concept with a wide range of renal replace- 

ment therapies. 

The setup of the tubing systems is clearly shown and 

explained step by step on the screen of the multiFiltrate 

multiFiltrate acute therapy machine: 

multiFiltrate basic Art. No. M20 070 1 

with Ci-Ca module Art.-Nr. M20 127 1 

4 Product Range – 01. 2010 Technical changes reserved

Range of therapies offered by the multiFiltrate 

acute therapy system 

Ci-Ca CVVHD 

Continuous veno-venous haemodialysis with 

citrate anticoagulation 

CVVHDF 

Continuous veno-venous haemodiafiltration 

CVVHD 

Continuous veno-venous haemodialysis 

Pre-Post CVVH 

Pre-post continuous veno-venous haemofiltration 

(High volume) 

CVVH 

Continuous veno-venous haemofiltration 

paed CVVH 

Paediatric continuous veno-venous haemofiltration 

paed CVVHD 

Paediatric continuous veno-venous haemodialysis 

SCUF 

Slow continuous ultrafiltration 

MPS 

Membrane plasma separation 

HP 

Hemoperfusion 


5

Complete kits for multiFiltrate 

The multiFiltrate cassette – safe and easy 

The multiFiltrate cassette consists of the arterial, venous 

and filtrate lines. This allows easy installation of the tub- 

ing systems required for each treatment. The combina- 

tion of the multiFiltrate cassette with treatment specific 

tubing systems enables the multiFiltrate to be set up 

quickly, safely and easily. 

multiFiltrate-Kit 

The multiFiltrate-Kits contain: 

• multiFiltrate cassette 

(AV-set and filtrate system pre-assembled) 

• Substituate and/or dialysate system 

(depends on therapy modality) 

• Haemofilter or plasmafilter 

Kit guideline chart SCUF CVVH Pre-Post CVVH CVVHDF CVVHD Ci-Ca CVVHD MPS HP paed CVVH paed CVVHD 

503 901 1 multiFiltrate Kit Ci-Ca CVVHD 1000 

503 887 1 multiFiltrate Kit 8 CVVHDF 1000 

503 893 1 multiFiltrate Kit 4 CVVHDF 600 

503 892 1 multiFiltrate Kit 3 CVVHD 600 

503 818 1 multiFiltrate Kit 7 HV-CVVH 1000 

503 879 1 multiFiltrate Kit 9 CVVH 1000 

503 891 1 multiFiltrate Kit 2 CVVH 600 

503 895 1 multiFiltrate Kit 6 MPS 2 

503 905 1 multiFiltrate Kit paed CRRT/SCUF 

= Dedicated usage, = Alternative usage 


Ci-Ca CVVHD 

Continuous veno-venous haemodialysis 

with citrate anticoagulation 

CVVHDF 

Continuous veno-venous 

haemodiafiltration 

multiFiltrate – Kit Ci-Ca CVVHD 1000 Art. No. 503 901 1 

Type Description 

Ultraflux ® AV 1000 S Ultraflux haemofilter, steam-sterilised, surface area 1.8 m2 , 

Fresenius High-Flux Polysulfone ® membrane 

multiFiltrate Ci-Ca Cassette multiFiltrate cassette with arterial and venous blood 

tubing systems, filtrate system and integrated citrate 

and calcium lines 

Dialysate system Dialysate system for multiFiltrate with integrated 

multiFiltrate heater bag 

multiFiltrate – Kit 8 CVVHDF 1000 Art. No. 503 887 1 


Ultraflux ® AV 1000 S Ultraflux ® haemofilter, steam-sterilised, 1.8 m2 surface 

area, Fresenius Polysulfone ® membrane 

multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial, 

venous and filtrate system 

Substituate System Substituate system for multiFiltrate with integrated 


Dialysate System Dialysate system for multiFiltrate with integrated 


multiFiltrate – Kit 4 CVVHDF 600 Art. No. 503 893 1 


Ultraflux ® AV 600 S Ultraflux ® haemofilter, steam-sterilised, 1.4 m 2 surface 









7

Complete kits for multiFiltrate 

CVVHD 


haemodialysis 

Pre-Post 

CVVH 

Pre-post continuous veno-venous 

haemofiltration (High volume) 

multiFiltrate – Kit 3 CVVHD 600 Art. No. 503 892 1 








multiFiltrate – Kit 7 HV-CVVH 1000 (High-Volume CVVH) Art. No. 503 818 1 






HV-CVVH Substituate 2 substituate lines for multiFiltrate with integrated heater 

Set multiFiltrate bags for pre- and postdilution 


CVVH 


haemofiltration 

MPS 

Membrane plasma separation 

multiFiltrate – Kit 9 CVVH 1000 Art. No. 503 879 1 








multiFiltrate – Kit 2 CVVH 600 Art. No. 503 891 1 



multiFiltrate – Kit 6 MPS 2 (Membrane Plasma Separation) Art. No. 503 895 1 







plasmaFlux PSu 2S Plasmafilter pre-filled with sterile water, steam-sterilised 

0.6 m 2 surface area, Fresenius Plasmasulfone membrane 



MPS Substituate Substituate System for multiFiltrate with 2 integrated 

System multiFiltrate heater bags, Luer-Lock male with 4 vented Spikes 

pre-connected 

Filtrate collection bag Filtrate collection bag, 10 L, with draining cock, 

Luer-Lock connector male 


9

multiFiltrate: paediatric CRRT and SCUF 

Safe and efficient treatment of babies, infants and adults 

A specifically developed multiFiltrate treatment-mode monitors the paediatric 

therapy. The Ultraflux ® AV paed haemofilter combined with special volume- 

reduced lines is used to perform paediatric CVVH in post- or predilution 

and CVVHD. 

Treatment parameters for paediatric treatment 

Parameters 

min. max. Increments Unit 

Blood flow 10 100 2 mL/min 

Ultrafiltration Off / 5 500 5 mL/h 

UF goal Off /10 5000 10 mL 

Cont. heparin adm. Off / 0.1 25 0.1 mL/h 

Dialysate 100 1500 10 mL/h 

Temperature Off / 35 39 0.5 °C 

multiFiltrate Kit paed CRRT/SCUF 

multiFiltrate – Kit paed CRRT/SCUF 

10 Product Range – 01. 2010 Technical changes reserved 

Type 

multiFiltrate paed 

CRRT/SCUF Set 

Ultraflux ® AV paed 

Ultraflux ® AV paed can only be used with holder for small dialysers 

Total extracorporeal blood volume is only 72 mL 

paed CVVH 

Paediatric continuous veno-venous 

haemofiltration 

paed CVVHD 

Paediatric continuous veno-venous 

haemodialysis

Art.-Nr. 503 905 1 

Description 

AV-Set paed, blood volume 54 mL, filtrate system and 

dialysate/substituate system packed as a set 

Ultraflux ® haemofilter, steam-sterilised, 

surface area 0.2 m 2 Fresenius High-Flux Polysulfone ® membrane 

(Art. No. M38 420 1) 

(AV-Set 54 mL; Filter 18 mL) 

SCUF 

Slow continuous ultrafiltration 

The combination of the Ultraflux ® AV paed haemofilter and the volume- 

reduced lines enables the user to perform an efficient continuous ultrafil- 

tration for adult and paediatric patients. 

Treatment parameters for SCUF treatment 

Parameters 

min. max. Increments Unit 

Blood flow 10 100 2 mL/min 

Ultrafiltration Off / 10 1200 10 mL/h 

UF goal Off /50 10000 50 mL 

Cont. heparin adm. Off / 0.1 25 0.1 mL/h 


11

CRRT haemofilters 

Ultraflux ® series 

Ultraflux ® filters contain a Fresenius Polysulfone ® 

membrane specifically developed for continuous 

renal replacement therapy. Successful treatments 

are achieved by: 

• Filter characteristics similar to those of the human 

kidney’s glomeruli 

Haemofilters 

Type Description Units per box Art. No. 

Ultraflux ® AV 400 S Ultraflux ® haemofilter, steam-sterilised, 0.75 m 2 surface area, 12 500 734 1 

Fresenius Polysulfone ® membrane, blood priming volume 52 mL 





Ultraflux ® AV paed Ultraflux ® haemofilter, steam-sterilised, 0.2 m 2 surface area, 20 500 823 1 


Luer-Lock Dialysate & Filtrate ports 

Ultraflux ® AV paed must only be used with the dialyser holder for small dialysers (Art. No. M38 420 1) 

• Retention of plasma proteins such as albumin, clotting 

factors, immunglobulins and cellular blood constituents 

• Excellent filter lifetimes 

• Easy handling 

• High biocompatibility 

• Mechanical stability 

• Filter size selectable to meet patient’s requirements 


Plasmafilters 

plasmaFlux ® series 

The hollow fibres of the plasmaFlux ® series sepa- 

rate cell-free plasma from whole blood in order to 

treat patients by plasma exchange or other plasma 

therapies. Requirements for successful treatments 

are fulfilled by the plasmaFlux ® filter characteristics: 

Plasmafilters 

Type Description Units per box Art. No. 

plasmaFlux PSu 1S Plasmafilter pre-filled with sterile water, steam-sterilised, 0.3 m 2 surface area, 10 500 491 1 

blood priming volume 36 mL, Fresenius Plasmasulfone membrane 

plasmaFlux PSu 2S Plasmafilter pre-filled with sterile water, steam-sterilised, 0.6 m 2 surface area, 10 500 481 1 

blood priming volume 70 mL, Fresenius Plasmasulfone membrane 

Inline steam sterilisation 

• Efficient extraction of pathogenic factors 

• High biocompatibility 

• Easy handling 

• Long filter lifetimes 

• Low extracellular volume 

• Minimum requirement for anticoagulation therapy 

Filters of the Ultraflux ® and plasmaFlux ® series are 100% leakage checked and steam- 

sterilized to offer a safe product that is free of any residues from the sterilization process. 


13

Solutions 

multiBic ® – bicarbonate-buffered haemofiltration solutions 

Larger, quieter, more convenient: 

When time is of the essence, every convenience helps. 

For example, the new multiBic ® double chamber bag 

with diagonal peel-seam for simpler handling. Thanks 

to 11% more content, the new 5 litre multiBic ® doesn’t 

need to be changed so often – leaving more time for 

other tasks. The improved gas barrier helps to keep the 

ready-to-use bicarbonate solution stable for longer so 

that the infusion of the patient can last up to 48 hours. 

The new 5 litre multiBic ® at a glance: 

• Mixing the two components provides 

100% bicarbonate-buffered haemofiltration solution 

• Always the right solution 

thanks to 4 different potassium concentrations 

• Fewer bag changes 

thanks to 11% more content 

• Increased solution stability, usable for up to 48 hrs. thanks to the improved gas barrier 

• Simpler handling 

thanks to the bag geometry with diagonal peel-seam 

• PVC, latex and DEHP-free, environmentally friendly thanks to use of “Biofine” material 

• Quieter 

thanks to the packaging’s softer, sound-reduced foil 

• Improved monitoring 

through the clear, transparent foil 

• Easier transport 

thanks to the new, comfortable handle 

• Suitable for almost all common CRRT appliances thanks to the bag eyelets and connectors 

• Addition of medication possible 

thanks to the injection port 


multiBic ® potassium-free, Solution for Haemofiltration 

multiBic ® 2 mmol/L potassium, Solution for Haemofiltration 



Composition: 1000 mL of the ready-to-use solution contain in mmol/L 

Excipients: 

Water for injections, hydrochloric acid (25%), carbon dioxide 

Indications: 

For use in patients with acute renal failure requiring continuous haemofiltration. 

Contraindications: 

Solution dependent contraindications: 

multiBic ® potassium-free/2/3 mmol/L potassium: 

– hypokalaemia 

– metabolic alkalosis 

multiBic ® 4 mmol/L potassium: 

– hyperkalaemia 

– metabolic alkalosis 

Haemofiltration dependent contraindications due to the technical procedure itself: 

– Renal failure with increased hypercatabolism in cases where uraemic symptoms 

can no longer be relieved by haemofiltration. 

– Inadequate blood flow from vascular access. 

– If there is a high risk of haemorrhage on account of systemic anticoagulation. 

multiBic ® potassium-free/2/3/4 mmol/L potassium is delivered in a doublechamber 

bag. One chamber (large compartment) contains the alkaline hydrogen 

carbonate solution, the other chamber (small compartment) contains the acidic 

glucose-based electrolyte solution. Mixing of both solutions by opening the 

peel-seam between the two chambers results in the ready-to-use solution. 

Name Theoret. 

Na + K + Ca ++ Mg ++ CI – HCO 3 – Glucose Osmol. 

multiBic ® mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mosm/L 

potassium-free 140 – 1.5 0.50 109 35 5.55 292 

2 mmol/L potassium 140 2.0 1.5 0.50 111 35 5.55 296 



pH 7.40 Availability depending on pharmaceutical product registration. 

Composition: 1000 mL of the ready-to-use solution contain in g/L 

Name Sodium Calcium Magnesium Glucose 

Sodium Potassium hydrogen chloride chloride mono- Equivalent 

multiBic ® chloride chloride carbonate dihydrate hexahydrate hydrate to glucose 

potassium-free 6.136 – 2.940 0.2205 0.1017 1.100 1.000 

2 mmol/L potassium 6.136 0.1491 2.940 0.2205 0.1017 1.100 1.000 



Order information Language/Art. No. 

Name D/NL/F/I GB/P/S/FIN E/TR/CZ/HU EST/LV/SK GB/HR/BiH RUS/UA 

DK/N PL/LT SLO/GR RO 

multiBic ® 2 × 5 L 2 × 5 L 2 × 5 L 2 × 5 L 2 × 5 L 2 × 5 L 

potassium-free 967 820 1 F00 001 138 F00 001 142 F00 001 146 F00 001 134 F00 001 300 

2 mmol/L potassium 967 920 1 F00 001 139 F00 001 143 F00 001 147 F00 001 135 F00 001 301 



Packaging: 5 litre bag, 2 bags per box, 104 bags per pallet 

Side effects: 

Adverse reactions, such as nausea, vomiting, muscle cramps, hypotension and 

hypertension, may result from the treatment mode itself or may be induced by 

the substitution solution. 

In general, the tolerability of bicarbonate buffered haemofiltration solution is good. 

However, the following potential side effects of the treatment can be anticipated: 

Hyper- or hypohydration, electrolyte disturbances (e. g. hypokalaemia), hypophosphataemia, 

hyperglycaemia, and metabolic alkalosis. 

Warnings and Precautions: 

Do not use unless solution is clear and the container is undamaged. Do not 

use before the two solutions have been mixed. The ready-to-use solution must 

be used within 48 hours after mixing. Any unused residual solution should be 

discarded. Do not store below +4°C. 

Date: November 2009 

Fresenius Medical Care Deutschland GmbH 

61346 Bad Homburg v.d.H., Germany 


15

Solutions 

Ci-Ca Solutions 

Citrate anticoagulation for CRRT – A beneficial system: 

• clearly reduced risk of bleeding 

• prolonged filter life-spans 

• Successful treatments of patients with HIT II 

The advantage of the Ci-Ca method is that it acts exclu- 

sively in the extracorporeal circuit making this method 

specifically attractive for intensive care patients and 

patients at risk of bleeding. 

Ci-Ca Dialysate K2 and Ci-Ca Dialysate K4 

The major role in regional citrate anticoagulation is 

assigned to the calcium-free Ci-Ca Dialysate. 

• two different potassium concentrations allow the 

adaption to the patient´s requirements 

• 5 L double chamber bag for safe and convenient 

handling 

• use of the mixed solutions for up to 48 h 


Ci-Ca Dialysate 

Article Art. no. Composition of the solution 

Na + 

Article Art. no. Composition of the solution 

Citrate mmol/L 

4% Na 3 citrate E2011 136 

Packaging: 1 litre bag, 7 bags/box pH adjustment with citric acid 

K + 


Ca ++ 

Mg ++ 

Cl – 

– 

HCO3 Glucose 

mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L g/L 

Ci-Ca Dialysate K2 968 920 1 133 2.0 0 0.75 116.5 20 1.0 

Ci-Ca Dialysate K4 F00 000 431 133 4.0 0 0.75 118.5 20 1.0 

Packaging: 5 litre bag Other constituents: water for injections, hydrochloric acid 25%, carbon dioxide 

2 bags per box 

Sodium Citrate 4% 

Saline solutions 

Type Art. no. Presentation Units per box Units per pallet 

Isotonic saline solutions 0.9% 131 067 1 30 × 250 mL 1,440 units 

(1 litre contains sodium chloride 9.0 g, 131 865 1 15 × 500 mL 720 units 

Na + 154 mmol/L, CI – 154 mmol/L) 131 866 1 10 × 1000 mL 480 units 

If products are categorised as pharmaceuticals, availability depending on pharmaceutical product registration. 

Sodium Citrate 4% 

Citrate solution for Ci-Ca therapy 

The citrate solution refrains coagulation by forming 

chelate complexes with the ionised calcium in blood. 

• 4% citrate solution and Ci-Ca Dialysate are adapted 

to each other 

• The citrate bag is equipped with a special 

connector to avoid misconnections 

17

Solutions 

multiPlus – The solution with physiological phosphate level 

multiPlus 

multiPlus (containing 1 mmol/L phosphate) prevents 

the depletion of phosphate during CRRT. 

• multiPlus prevents the development of hypophosphatemia 

• Phosphate und glucose ensure the adequate provision 

of energy rich components for metabolic proc- 

esses and may support the weaning from mechani- 

cal ventilation. 

Article Art. No. Composition of the solution: 

Na + 

K + 

Ca ++ 


Mg ++ 

Cl – 

– 

HCO3 Inorganic Phosphate Glucose 

mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L g/L 

multiPlus 968 820 1 140 2.0 1.5 0.75 109.7 35 1.0 1.0 

Packaging: 5 litre bag, Other constituents: water for injection, hydrochloric acid 25%, carbon dioxide 

2 bags per box

Solutions 

Lactate-buffered haemofiltration solutions 

Type/Art. No. Composition of the ready-to-use solution in mmol/L: 

Name 2 × 2 × Na + K + Ca ++ Mg ++ CI – Lactate – Theoret. Osmol 

4.5 L 5.0 L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mosm/L 

HF 11 207 659 1 – 140 1 1.625 0.75 100.75 45 300 

HF 12 – 207 720 1 140 1 1.875 0.75 100.75 45.5 301 

HF 23 208 159 1 – 140 2 2.125 0.75 112.0 35.75 301 

HF 24 208 259 1 – 142 2 2 0.75 105.0 44.5 296 

Availability depending on pharmaceutical product registration. 

Type/Art. No. Composition of the ready-to-use solution in g/L: 

Name 2 × 2 × Sodium Calcium Magnesium Glucose 

4.5 L 5.0 L Sodium lactate Sodium Potassium chloride chloride mono- Glucose 

Indications: 

1. End stage chronic renal disease (decompensation) of all origins 

2. Acute renal failure not accompanied by hypercatabolism 

3. Cardiac insufficiency not easily influenced by medicaments and caused by 

hyperhydratation 

4. Acute states of intoxication caused by non-protein-bound poisons; use either 

alone or in conjunction with other detoxication measures (haemodialysis, 

peritoneal dialysis and/or haemoperfusion) 

5. Metabolic disturbance resulting from end stage chronic renal failure 

Contraindications: 

Contraindications caused by the treatment: 

1. Acute renal failure accompanied by marked hypercatabolic conditions in cases 

where uraemic symptoms can no longer be relieved by haemofiltration 

2. Insufficient blood flow from the shunt 

3. Recent cerebral or internal (parenchymatous) haemorrhages 

Contraindications caused by the solution: 

HF 11: 

1. Hypokalaemia 

2. Impairment of lactate metabolism/lactate acidosis 

chloride solution lactate chloride • 2 H 2 O • 6 H 2 O hydrate (waterfree) 

HF 11 207 659 1 – 5.552 10.09 5.045 0.0746 0.2389 0.1525 2.154 1.9581 

HF 12 – 207 720 1 5.52 10.2 5.1 0.0746 0.2756 0.1525 2.154 1.96 

HF 23 208 159 1 – 6.09 8.02 4.01 0.1492 0.3124 0.1525 1.65 1.5 

HF 24 208 259 1 – 5.698 9.98 4.99 0.1492 0.294 0.1525 – – 

Number of units per pallet: 112 Other constituents: water for injections, hydrochloric acid, sodium hydroxide 

56 boxes, each containing two bags. 

HF 12, HF 23, HF 24: 

1. Hypokalaemia 

2. Hypercalcemia 

3. Impairment of lactate metabolism/lactate acidosis 

Note: 

HF 11, HF 12, HF 23: 

In cases of marked hyperhydration and marked dehydration (high ultrafiltration), 

it is advisable to use a solution with a higher sodium content, taking into 

account the serum sodium concentration of the patient. 

HF 11, 12: 

In diabetic patients receiving insulin, the dose of insulin should be adjusted as 

appropriate for the glucose content of the haemofiltration solution. 

Side effects: 

None have been observed up to the present. 

Warnings and precautions: 

Do not store above +25°C. Do not use unless solution is clear and the container 

is undamaged. 

Date: November 2009 

Fresenius Medical Care Deutschland GmbH, 

61346 Bad Homburg v.d.H., Germany 


19

Temporary dialysis catheters 

Fresenius Medical Care has developed temporary dialy- 

sis catheters specifically for the use in acute therapies. 

They ensure a rapid and safe central venous vascular 

access via the jugular, subclavian or femoral vein. 

High flow double lumen catheter sets* 

Type Size and length Article No. 

TH1415 14.5 F × 150 mm 507 780 1 

TH1417 14.5 F × 175 mm 507 782 1 

TH1420 14.5 F × 200 mm 507 783 1 

TH1424 14.5 F × 240 mm 507 784 1 

Double lumen catheter sets* 

Type Size and length Article No. 

TD1115 11 F × 150 mm 502 877 1 

TD1117 11 F × 175 mm 502 874 1 

TD1120 11 F × 200 mm 502 878 1 

* Included accessories: Seldinger puncture cannula (17 G × 70 mm), 

guide wire (0.95 × 700 mm), step dilatator, injection closure caps, CathClip 

High flow double lumen catheter 

• Double lumen shaft geometry in combination 

with large inlet and outlet ports at the catheter tip 

ensure a low flow resistance also at high blood 


flows 

• Soft catheter tip – minimises the risk of vascular 

lesions upon catheter placement 

• Excellent kinking stability 

• Optimal range of application: blood flows between 

150 mL/min and 400 mL/min 

Standard double lumen catheter 

• Contralaterally arranged inlet and outlet ports 

reduce recirculation 

• Optimal range of application: blood flows up to 

200 mL/min 

• Soft catheter tip – minimises the risk of vascular 

lesions upon catheter placement

Disposables and accessories 

Waste bags 

Type Description Connection Units per box Art. No. 

Waste bag 2000 mL Waste bag with female Luer-Lock connector 100 501 509 1 

PF waste bag 5000 mL Waste bag with male Luer-Lock connector for single use 50 501 510 1 

Filtrate bag 10 L Filtrate collection bag with draining cock, 

male Luer-Lock connector 

40 502 901 1 

Filtrate bag 10 L Filtrate collection bag with male Luer-Lock, 40 502 903 1 

Single use single use 

Accessories 

Type Description Connection Units per box Art. No. 

Scissor clamp For clamping lines 5 284 024 1 

Freka-Flex Infusion set Infusion set with roller clamp and drip 

chamber male Luer-lock 

150 288 901 1 

Pressure monitor line Pressure monitor line with filter, 

connector female/male Luer-Lock, length 30 cm 

100 501 463 1 

PF-Adapter HF female/ 

Luer-Lock female 

Connection of infusion sets to HF tubing 100 501 474 1 

Adapter 

Luer-Lock male 

Connector 2 male Luer-Lock 100 501 477 1 

Adapter 

Luer-Lock female 

Connector 2 female Luer-Lock 100 501 480 1 

Filtrate adapter Luer-Lock female CVVH/D adapter 

to the filtrate outlet of a dialyser 

100 501 491 1 

Transducer Protector Pressure filter, connector male/female Luer-Lock 100 501 591 1 

Spike female Luer-Lock/Spike 100 501 592 1 

Vented Spike female Luer-Lock/Spike (vented) 100 F0000520 

HF female/ Connection of bags with septum to 100 501 635 1 

spike adapter HF tubing system 

Adapter HF female/ Connection of 100 501 689 1 

Luer-Lock male rinsing solution to HF tubing 

Pressure measurement Pressure monitor line with filter, 200 501 915 1 

line 60 cm connector male/female Luer-Lock, length 60 cm, 

for arterial pressure measurement 

SN-adapter Y-adapter, 

2 × female Luer-Lock/1 × male Luer-Lock 

100 502 785 1 

Adapter 2 × HF female / 

4 × HF male 

To connect 4 HF bags to HF tubings 30 504 613 1 

Adapter Luer-Lock female/ To connect 6 HF solutions to a substituate 30 504 602 1 

6 × HF male (FSG102) system 

Check valve Check valve male Luer-Lock/ 

female Luer-Lock 

100 850 280 2 

Heparin syringe 50 mL Fresenius Injectomat syringe, latex-free, male Luer-Lock 100 900 071 1 

Heparin syringe 50 mL Fresenius P-syringe, latex-free, male Luer-Lock 100 900 076 1 


21

Order list 

Hospital/Dept. 

Title/Name 

Street 

Country/Postal code/City 

Customer No. 

Art. No. Article Amount Price 



23

Head office: Fresenius Medical Care Deutschland GmbH · 61346 Bad Homburg v. d. H. · Germany · Phone: +49 (0) 6172-609-0 · Fax: +49 (0) 6172-609-2191 

www.fmc-ag.com 

732 656 1/8 GB (1 PUR-xx 01.10) © Copyright 2010 Fresenius Medical Care Deutschland GmbH · Technical changes reserved

Product Range - Fresenius Medical Care Sverige AB

Create successful ePaper yourself

Delete template?

Save as template?